Zobrazeno 1 - 10
of 349
pro vyhledávání: '"Barry, S. Coller"'
Publikováno v:
MedEdPublish, Vol 14 (2024)
Background One recent trend in medical education is the integration of humanities into the curriculum, including viewing works of art in museums, with analysis of short-term, but not long-term, impact. We developed a course for medical students, trai
Externí odkaz:
https://doaj.org/article/31c80ac4039246399d5e2a1cf76acf1d
Autor:
Giuseppe De Luca, Ashley Verburg, Arnoud van’t Hof, Jurrien ten Berg, Dean J. Kereiakes, Barry S. Coller, Charles Michael Gibson
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2023 (2024)
Acute myocardial infarction still represents the major cause of mortality in high-income countries. Therefore, considerable efforts have been focused on the treatment of myocardial infarctions in the acute and long-term phase, with special attention
Externí odkaz:
https://doaj.org/article/b8de5fb538254d91b06a14e94ad39289
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 147-147 (2024)
OBJECTIVES/GOALS: The research objectives of this project are to elucidate the effects of Bruton’s tyrosine kinase inhibitors (BTKi) of varying target specificity on platelet function with regard to platelet aggregation, adhesion, spreading, and in
Externí odkaz:
https://doaj.org/article/10c692bb0e754df0abeb557be343434a
Autor:
Sem A. O. F. Rikken, Arnoud W. J. van 't Hof, Jurriën M. ten Berg, Dean J. Kereiakes, Barry S. Coller
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 24 (2023)
Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 p
Externí odkaz:
https://doaj.org/article/789d3593397e4ef4aaf7cdb7865ef657
Autor:
Rhonda G. Kost, Rita K. Devine, Mark Fernands, Riva Gottesman, Manoj Kandpal, Robert B. MacArthur, Barbara O’Sullivan, Michelle Romanick, Andrea Ronning, Sarah Schlesinger, Jonathan N. Tobin, Roger Vaughan, Maija Neville-Williams, James G. Krueger, Barry S. Coller
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Abstract Introduction: Clinical trials are a vital component of translational science, providing crucial information on the efficacy and safety of new interventions and forming the basis for regulatory approval and/or clinical adoption. At the same
Externí odkaz:
https://doaj.org/article/2c491e0718d2494eb07cd2435ab8b0d4
Publikováno v:
Journal of Clinical and Translational Science, Vol 7, Pp 86-86 (2023)
OBJECTIVES/GOALS: Low-dose aspirin is an established treatment to prevent preeclampsia, a leading cause of maternal and perinatal complications. Nevertheless, aspirin failure is not uncommon. We are investigating whether a gain-of-function genetic po
Externí odkaz:
https://doaj.org/article/cc905ef11d1141ae999996207a619491
Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
Autor:
Jordan Spradbrow, Sasha Letourneau, Julie Grabell, Yupu Liang, James Riddel, Wilma Hopman, Victor S. Blanchette, Margaret L. Rand, Barry S. Coller, Andrew D. Paterson, Paula D. James
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 1, Pp 92-99 (2020)
Abstract Background Bleeding assessment is part of the diagnostic workup of von Willebrand disease (VWD). Bleeding assessment tools (BATs) have standardized obtaining this information but have been criticized because they are time consuming. Objectiv
Externí odkaz:
https://doaj.org/article/2908119b4e5244759debe0e1f14093fe
Autor:
Susan S. Smyth, Barry S. Coller, Rebecca D. Jackson, Philip A. Kern, Scott McIntosh, Emma A. Meagher, Doris M. Rubio, Kathryn Sandberg, Joel Tsevat, Jason G. Umans, Jacqueline Attia, Heather L. Baker, Joan D. Nagel, Colleen A. McMullen, Erica Rosemond
Publikováno v:
Journal of Clinical and Translational Science, Vol 6 (2022)
Abstract Introduction: Identifying the most effective ways to support career development of early stage investigators in clinical and translational science should yield benefits for the biomedical research community. Institutions with Clinical and T
Externí odkaz:
https://doaj.org/article/b61b7887c4b34f5dbc213c861f6a2162
Autor:
Sem A.O.F. Rikken, Willem L. Bor, Abi Selvarajah, Kai L. Zheng, Amy P. Hack, C. Michael Gibson, Christopher B. Granger, Ohad S. Bentur, Barry S. Coller, Arnoud W.J. van ’t Hof, Jurriën M. ten Berg
Publikováno v:
American Heart Journal. 262:75-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::277c33e761c3ab3b3528e824b7c0055e
https://doi.org/10.1016/j.ahj.2023.04.009
https://doi.org/10.1016/j.ahj.2023.04.009
Autor:
Ohad S. Bentur, Jihong Li, Caroline S. Jiang, Linda H. Martin, Dean J. Kereiakes, Barry S. Coller
Publikováno v:
TH Open, Vol 05, Iss 03, Pp e449-e460 (2021)
Introduction Prehospital therapy of ST-elevation myocardial infarction (STEMI) with αIIbβ3 antagonists improves clinical outcomes, but they are difficult to use in prehospital settings. RUC-4 is a novel αIIbβ3 antagonist being developed for preho
Externí odkaz:
https://doaj.org/article/44739d156a174cadbbd7ae35ef38e4b8